Loading...
Keywords
Last Name
Institution

Tarak Srivastava

Concepts (397)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Nephrotic Syndrome
18
2024
27
4.000
Why?
Podocytes
10
2021
12
3.770
Why?
Kidney Glomerulus
13
2024
19
3.680
Why?
Glomerulosclerosis, Focal Segmental
15
2024
22
3.360
Why?
Glomerular Filtration Rate
9
2021
112
3.200
Why?
Receptors, Prostaglandin E, EP2 Subtype
5
2022
5
3.180
Why?
Renal Insufficiency, Chronic
8
2023
188
2.840
Why?
Dinoprostone
6
2022
8
2.320
Why?
Stress, Mechanical
7
2021
9
2.090
Why?
Humans
76
2024
6579
1.990
Why?
Calcimimetic Agents
4
2018
7
1.930
Why?
Kidney
11
2024
90
1.900
Why?
Creatinine
8
2022
52
1.760
Why?
Male
48
2022
3113
1.740
Why?
Nephrosis, Lipoid
6
2024
6
1.700
Why?
Calcium
8
2018
39
1.650
Why?
Animals
17
2024
674
1.650
Why?
Mechanotransduction, Cellular
3
2021
5
1.610
Why?
Diphosphonates
8
2012
13
1.510
Why?
Hypercalciuria
4
2009
4
1.350
Why?
Female
39
2023
3362
1.320
Why?
Familial Hypophosphatemic Rickets
3
2022
9
1.270
Why?
Child
43
2023
3193
1.250
Why?
Kidney Diseases
8
2023
69
1.230
Why?
Mice
10
2024
296
1.190
Why?
Vitamin D
5
2019
22
1.110
Why?
Child, Preschool
27
2020
1476
1.060
Why?
Adolescent
30
2023
2078
1.030
Why?
beta Catenin
2
2022
9
1.010
Why?
Nephrectomy
5
2018
15
1.000
Why?
Parathyroid Hormone
6
2018
24
1.000
Why?
Living Donors
2
2018
7
0.950
Why?
Interleukin-6
2
2021
10
0.940
Why?
Cyclooxygenase 2
3
2022
5
0.920
Why?
Kidney Failure, Chronic
4
2022
162
0.840
Why?
Kidney Transplantation
4
2023
110
0.800
Why?
Prenatal Exposure Delayed Effects
1
2021
8
0.790
Why?
Glomerulonephritis
4
2021
8
0.770
Why?
Pseudohypoparathyroidism
2
2015
2
0.770
Why?
Proteoglycans
1
2020
2
0.760
Why?
Transcriptional Activation
1
2020
9
0.760
Why?
Albuminuria
5
2022
12
0.750
Why?
Acute-Phase Reaction
2
2011
2
0.740
Why?
Proteinuria
8
2023
26
0.730
Why?
Nephrology
3
2022
18
0.700
Why?
Receptors, Prostaglandin E, EP4 Subtype
2
2022
2
0.670
Why?
Infant
15
2019
1394
0.650
Why?
Hypertension
3
2018
61
0.640
Why?
Furosemide
1
2017
1
0.630
Why?
Hypercalcemia
4
2012
10
0.630
Why?
Hyperparathyroidism, Secondary
1
2017
9
0.620
Why?
Urologic Diseases
1
2017
2
0.610
Why?
Eicosanoids
1
2017
1
0.600
Why?
Mechanical Phenomena
1
2017
1
0.600
Why?
Immunosuppressive Agents
5
2015
32
0.570
Why?
Adult
17
2023
1139
0.560
Why?
Mice, Transgenic
3
2024
33
0.550
Why?
Genetic Predisposition to Disease
4
2020
218
0.550
Why?
Bone Remodeling
1
2015
1
0.550
Why?
Urinary Tract Infections
2
2009
17
0.520
Why?
Cell Cycle Proteins
2
2006
15
0.510
Why?
Young Adult
11
2023
616
0.510
Why?
Renal Circulation
1
2014
6
0.500
Why?
Up-Regulation
4
2020
25
0.480
Why?
Infusions, Intravenous
2
2011
27
0.470
Why?
Urolithiasis
2
2012
2
0.470
Why?
Naphthalenes
1
2013
6
0.460
Why?
Obesity
3
2021
123
0.460
Why?
Vitamin D Deficiency
2
2019
10
0.460
Why?
Receptors, Prostaglandin E, EP1 Subtype
1
2012
1
0.450
Why?
Cell Line
3
2021
80
0.430
Why?
Treatment Outcome
8
2023
633
0.420
Why?
Osteoporosis
4
2012
25
0.410
Why?
Cardiovascular Diseases
2
2023
45
0.400
Why?
Signal Transduction
3
2017
126
0.400
Why?
Microfilament Proteins
2
2001
12
0.400
Why?
Bone Diseases, Metabolic
4
2018
8
0.400
Why?
Biomarkers
4
2022
126
0.400
Why?
Nephroma, Mesoblastic
1
2010
1
0.390
Why?
Parathyroid Hormone-Related Protein
1
2010
1
0.390
Why?
Bone Density
3
2012
44
0.390
Why?
Kidney Neoplasms
1
2010
11
0.390
Why?
Time Factors
6
2015
254
0.380
Why?
Disease Progression
6
2023
104
0.380
Why?
Phospholipase C gamma
2
2024
2
0.370
Why?
Cytokines
4
2017
48
0.370
Why?
Kidney Function Tests
2
2012
21
0.370
Why?
Citric Acid
1
2009
2
0.350
Why?
Nephrolithiasis
1
2009
1
0.350
Why?
Hematuria
1
2009
7
0.350
Why?
Heptanoic Acids
1
2009
1
0.340
Why?
Pyrroles
1
2009
1
0.340
Why?
Radioisotope Dilution Technique
1
2009
1
0.340
Why?
Mass Spectrometry
1
2009
17
0.340
Why?
Reagent Kits, Diagnostic
1
2009
12
0.340
Why?
Risk Factors
6
2023
471
0.330
Why?
Models, Biological
1
2009
61
0.320
Why?
Albumins
3
2022
7
0.320
Why?
Disease Models, Animal
2
2021
57
0.320
Why?
Abdominal Pain
1
2009
64
0.320
Why?
Mice, Inbred C57BL
2
2021
78
0.320
Why?
Rickets
2
2010
2
0.310
Why?
Urinary Calculi
2
2005
3
0.300
Why?
Biomechanical Phenomena
2
2017
8
0.300
Why?
Body Fluids
1
2007
1
0.300
Why?
Nitrogen
1
2007
1
0.300
Why?
Dialysis Solutions
1
2007
19
0.300
Why?
Diagnostic Techniques, Urological
1
2006
1
0.290
Why?
Medical Laboratory Science
1
2006
1
0.290
Why?
HLA-DQ alpha-Chains
2
2017
3
0.290
Why?
Steroids
2
2017
14
0.280
Why?
Acute Kidney Injury
2
2007
28
0.280
Why?
Uric Acid
2
2005
6
0.280
Why?
Bone Density Conservation Agents
3
2012
10
0.270
Why?
Membrane Proteins
2
2006
51
0.270
Why?
Infant, Newborn
6
2023
785
0.270
Why?
Birth Weight
2
2023
28
0.260
Why?
Cohort Studies
6
2023
262
0.260
Why?
Reproducibility of Results
3
2011
191
0.240
Why?
Age Factors
3
2018
204
0.240
Why?
Paraffin
1
2003
2
0.240
Why?
Urine
1
2003
2
0.240
Why?
Protons
1
2003
6
0.240
Why?
Circadian Rhythm
1
2003
7
0.240
Why?
Specimen Handling
1
2003
17
0.240
Why?
Adaptor Proteins, Signal Transducing
1
2024
37
0.230
Why?
Middle Aged
6
2021
613
0.230
Why?
Premature Birth
1
2023
7
0.230
Why?
Recurrence
5
2023
119
0.230
Why?
Tobacco Smoke Pollution
1
2023
5
0.230
Why?
Gonadal Steroid Hormones
1
2022
2
0.220
Why?
Proto-Oncogene Proteins c-akt
1
2022
9
0.220
Why?
Fibroblast Growth Factors
1
2022
27
0.220
Why?
Hypoxanthine Phosphoribosyltransferase
1
2002
2
0.210
Why?
Protein Tyrosine Phosphatases
1
2001
4
0.210
Why?
Central Nervous System
1
2001
9
0.210
Why?
Genetic Variation
2
2020
163
0.210
Why?
Biopsy
4
2023
60
0.210
Why?
Pneumonia
1
2002
31
0.210
Why?
Proteins
1
2001
24
0.210
Why?
Janus Kinase 2
3
2017
8
0.200
Why?
Organ Size
1
2021
13
0.200
Why?
Genes, fos
1
2021
1
0.200
Why?
Lymphoid Enhancer-Binding Factor 1
1
2021
1
0.200
Why?
Transcription Factor 3
1
2021
1
0.200
Why?
Cell Cycle
1
2021
16
0.200
Why?
Lac Operon
1
2021
2
0.200
Why?
Animals, Newborn
1
2021
25
0.200
Why?
Regression Analysis
2
2011
52
0.200
Why?
Retrospective Studies
8
2023
1278
0.200
Why?
Apoptosis
1
2021
44
0.200
Why?
Databases, Genetic
1
2021
25
0.200
Why?
Promoter Regions, Genetic
1
2021
48
0.200
Why?
Low Density Lipoprotein Receptor-Related Protein-2
1
2020
1
0.190
Why?
Peritoneal Dialysis
3
2007
148
0.190
Why?
Complement C1q
1
2000
3
0.190
Why?
TOR Serine-Threonine Kinases
1
2020
5
0.190
Why?
Pregnancy
1
2021
188
0.190
Why?
Pain
2
2012
55
0.180
Why?
Osteoporosis, Postmenopausal
1
1999
1
0.180
Why?
Bone Diseases
1
1999
4
0.180
Why?
Mycophenolic Acid
2
2012
6
0.180
Why?
Cyclosporine
2
2012
6
0.180
Why?
Lymphoproliferative Disorders
1
1999
4
0.180
Why?
Follow-Up Studies
6
2019
326
0.180
Why?
Osteogenesis Imperfecta
1
1999
8
0.180
Why?
Genes, Dominant
1
1999
5
0.180
Why?
Bezoars
1
1999
2
0.180
Why?
Candidiasis
1
1999
4
0.180
Why?
Polycystic Kidney Diseases
1
1999
3
0.180
Why?
Mutation, Missense
3
2014
24
0.170
Why?
Edema
1
2019
7
0.170
Why?
Antibodies, Monoclonal, Humanized
3
2022
34
0.170
Why?
Immunohistochemistry
3
2006
41
0.170
Why?
Anemia, Sickle Cell
1
2019
17
0.170
Why?
Bone Resorption
2
2012
2
0.170
Why?
Adrenocorticotropic Hormone
1
2018
3
0.170
Why?
Spiro Compounds
1
2018
1
0.170
Why?
Endothelin A Receptor Antagonists
1
2018
1
0.170
Why?
Angiotensin II Type 1 Receptor Blockers
1
2018
6
0.170
Why?
Cyclooxygenase 2 Inhibitors
1
2018
3
0.170
Why?
Sulfonamides
1
2018
10
0.170
Why?
Renin-Angiotensin System
1
2018
5
0.170
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2018
15
0.170
Why?
Receptors, Calcitriol
2
2010
9
0.170
Why?
Tissue and Organ Procurement
1
2018
16
0.170
Why?
Aging
1
2018
32
0.160
Why?
Hyperparathyroidism
1
2018
1
0.160
Why?
Receptors, Calcium-Sensing
1
2018
1
0.160
Why?
Graft Rejection
1
2018
32
0.160
Why?
Quality of Life
1
2019
135
0.160
Why?
Blood Pressure Determination
1
2017
14
0.150
Why?
Reference Values
2
2011
43
0.150
Why?
Prospective Studies
4
2023
520
0.150
Why?
Rats, Sprague-Dawley
2
2015
46
0.150
Why?
United States
3
2017
640
0.150
Why?
Rats
2
2015
107
0.150
Why?
Magnetic Resonance Imaging
1
2017
115
0.150
Why?
Ambulatory Care
1
2017
45
0.150
Why?
Chromogranins
1
2015
2
0.140
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2015
2
0.140
Why?
Calcitriol
1
2015
6
0.140
Why?
Phosphates
1
2015
13
0.140
Why?
Dietary Supplements
1
2015
18
0.140
Why?
Exons
1
2015
34
0.140
Why?
Galactose
1
2015
1
0.130
Why?
Adalimumab
1
2015
2
0.130
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2015
7
0.130
Why?
Blood Cells
1
2015
2
0.130
Why?
Glomerular Filtration Barrier
1
2015
1
0.130
Why?
STAT3 Transcription Factor
1
2015
7
0.130
Why?
Cyclins
2
2006
2
0.130
Why?
Cyclin A
2
2006
2
0.130
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2006
2
0.130
Why?
Cyclin-Dependent Kinase Inhibitor p57
2
2006
2
0.130
Why?
Cyclin D
2
2006
2
0.130
Why?
Hydroxyeicosatetraenoic Acids
1
2014
1
0.130
Why?
Alcohol Dehydrogenase
1
2014
4
0.130
Why?
Ethanol
1
2014
7
0.130
Why?
Phenotype
1
2015
244
0.130
Why?
DNA Methylation
1
2015
108
0.130
Why?
Age of Onset
3
2023
28
0.130
Why?
Cyclooxygenase Inhibitors
1
2014
4
0.130
Why?
Mice, 129 Strain
1
2014
2
0.130
Why?
Giant Cell Tumors
2
1992
2
0.130
Why?
Bone Transplantation
2
1992
9
0.120
Why?
Bone Neoplasms
2
2012
24
0.120
Why?
Genotype
3
2023
401
0.120
Why?
Pain Measurement
2
2012
48
0.120
Why?
RNA, Messenger
1
2014
111
0.120
Why?
Aged
3
2019
393
0.120
Why?
Nephrons
1
2013
1
0.120
Why?
Filtration
1
2013
2
0.120
Why?
Urogenital Abnormalities
1
2013
5
0.120
Why?
Neptune
2
2023
2
0.110
Why?
Diffusion Chambers, Culture
1
2012
1
0.110
Why?
Prognosis
3
2018
213
0.110
Why?
Fluorescent Antibody Technique
1
2012
8
0.110
Why?
Incidence
3
2017
128
0.110
Why?
Cell Division
2
2003
10
0.110
Why?
Alleles
3
2021
206
0.110
Why?
Osteoclasts
1
2012
4
0.110
Why?
Real-Time Polymerase Chain Reaction
1
2012
39
0.110
Why?
Dexamethasone
1
2012
30
0.110
Why?
Cartilage
1
2012
2
0.110
Why?
Gene Expression Regulation
1
2012
100
0.110
Why?
Bone Cysts
1
1992
1
0.110
Why?
Predictive Value of Tests
2
2009
99
0.100
Why?
Drug Administration Schedule
2
2018
36
0.100
Why?
Drug Resistance
3
2018
6
0.100
Why?
Dose-Response Relationship, Drug
2
2018
92
0.100
Why?
Infant, Premature
1
2010
81
0.090
Why?
Alopecia
1
2010
2
0.090
Why?
Likelihood Functions
1
2009
5
0.090
Why?
Anticholesteremic Agents
1
2009
2
0.090
Why?
Placebos
1
2009
4
0.090
Why?
Oxycodone
1
2009
4
0.090
Why?
Technetium Tc 99m Pentetate
1
2009
1
0.090
Why?
Radiopharmaceuticals
1
2009
5
0.090
Why?
C-Reactive Protein
1
2009
16
0.090
Why?
Calibration
1
2009
7
0.090
Why?
Kinetics
1
2009
34
0.090
Why?
Acetaminophen
1
2009
18
0.080
Why?
Loop of Henle
1
2007
1
0.080
Why?
Intestinal Absorption
1
2007
2
0.080
Why?
DNA Mutational Analysis
2
2010
37
0.080
Why?
Base Sequence
2
2010
83
0.070
Why?
Chemistry, Clinical
1
2007
2
0.070
Why?
Drainage
1
2007
35
0.070
Why?
Anions
1
2006
1
0.070
Why?
Osmolar Concentration
1
2006
5
0.070
Why?
Acute Disease
2
2008
76
0.070
Why?
Receptors, Cytokine
2
2017
2
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
1
0.070
Why?
Data Interpretation, Statistical
1
2006
20
0.070
Why?
Permeability
2
2017
7
0.070
Why?
Midwestern United States
2
2019
35
0.070
Why?
Sex Distribution
2
2017
17
0.070
Why?
G1 Phase
1
2006
2
0.070
Why?
S Phase
1
2006
3
0.070
Why?
Age Distribution
2
2017
31
0.070
Why?
Capillary Permeability
1
2006
3
0.070
Why?
Cyclophosphamide
1
2006
8
0.070
Why?
Hypoalbuminemia
1
2006
4
0.070
Why?
Prednisone
1
2006
12
0.070
Why?
Autoantibodies
1
2006
9
0.070
Why?
Immunoglobulin G
1
2006
33
0.070
Why?
Antibodies, Monoclonal
1
2006
23
0.070
Why?
Case-Control Studies
2
2017
208
0.070
Why?
Phosphorylation
2
2015
21
0.070
Why?
Cystinuria
1
2005
1
0.070
Why?
Xanthine
1
2005
1
0.070
Why?
Mutation
1
2006
197
0.060
Why?
Food
1
2005
17
0.060
Why?
Pediatrics
1
2006
173
0.060
Why?
Refrigeration
1
2003
1
0.060
Why?
Syringes
1
2003
1
0.060
Why?
Hydrogen-Ion Concentration
1
2003
21
0.060
Why?
Densitometry
1
2003
1
0.060
Why?
Controlled Clinical Trials as Topic
1
2003
2
0.060
Why?
Patient Transfer
1
2023
8
0.060
Why?
Proto-Oncogene Proteins p21(ras)
1
2003
3
0.060
Why?
Infant, Low Birth Weight
1
2023
14
0.060
Why?
Transition to Adult Care
1
2023
18
0.060
Why?
Apolipoproteins
1
2023
5
0.060
Why?
Cotinine
1
2023
4
0.060
Why?
Tumor Suppressor Proteins
1
2003
15
0.060
Why?
Rituximab
1
2023
3
0.060
Why?
Drug Therapy, Combination
2
2013
37
0.060
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2022
1
0.060
Why?
Tumor Necrosis Factors
1
2022
1
0.060
Why?
Nuclear Proteins
1
2003
45
0.060
Why?
Biological Assay
1
2022
3
0.060
Why?
Severity of Illness Index
1
2003
144
0.060
Why?
Renal Dialysis
1
2023
101
0.050
Why?
Complement C3
1
2002
3
0.050
Why?
Thioguanine
1
2002
8
0.050
Why?
Erythrocytes
1
2002
11
0.050
Why?
T-Lymphocytes
1
2002
30
0.050
Why?
Diagnosis, Differential
1
2002
77
0.050
Why?
DNA
1
2002
42
0.050
Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 3
1
2001
4
0.050
Why?
Syndrome
1
2001
34
0.050
Why?
Medication Adherence
1
2021
21
0.050
Why?
Atypical Hemolytic Uremic Syndrome
1
2021
1
0.050
Why?
Glomerular Mesangium
1
2001
1
0.050
Why?
Length of Stay
1
2002
232
0.050
Why?
Antigen-Antibody Complex
1
2000
2
0.050
Why?
Mice, Knockout
1
2020
54
0.050
Why?
Surveys and Questionnaires
1
2021
262
0.050
Why?
Epstein-Barr Virus Infections
1
1999
3
0.050
Why?
Ganciclovir
1
1999
3
0.050
Why?
Administration, Oral
1
1999
57
0.040
Why?
Urography
1
1999
2
0.040
Why?
Ureteral Obstruction
1
1999
5
0.040
Why?
Antiviral Agents
1
1999
26
0.040
Why?
Endoscopy
1
1999
16
0.040
Why?
Antifungal Agents
1
1999
13
0.040
Why?
Ultrasonography
1
1999
45
0.040
Why?
Self Report
1
2019
39
0.040
Why?
Double-Blind Method
1
2018
39
0.040
Why?
Longitudinal Studies
1
2019
112
0.040
Why?
Preoperative Period
1
2018
5
0.040
Why?
Renal Elimination
1
2018
1
0.040
Why?
Allosteric Regulation
1
2018
2
0.040
Why?
Glucocorticoids
1
2018
29
0.040
Why?
Postoperative Complications
1
1999
194
0.040
Why?
Calcineurin Inhibitors
1
2017
2
0.040
Why?
Diabetes Mellitus, Type 1
1
1999
107
0.040
Why?
Hypertension, Malignant
1
2017
1
0.040
Why?
Observer Variation
1
2017
13
0.040
Why?
Proportional Hazards Models
1
2017
37
0.040
Why?
Risk Assessment
1
2017
131
0.040
Why?
Blood Pressure
1
2017
58
0.040
Why?
Receptors, Urokinase Plasminogen Activator
1
2015
3
0.030
Why?
Actin Cytoskeleton
1
2015
1
0.030
Why?
Kidney Cortex
1
2015
2
0.030
Why?
Bone Marrow Cells
1
2015
6
0.030
Why?
Recombinant Proteins
1
2015
51
0.030
Why?
B-Lymphocytes
1
2015
23
0.030
Why?
Protein Multimerization
1
2015
3
0.030
Why?
Antibodies, Blocking
1
2015
3
0.030
Why?
Protein Kinase Inhibitors
1
2015
5
0.030
Why?
Spleen
1
2015
29
0.030
Why?
Adrenal Cortex Hormones
1
2015
35
0.030
Why?
Protein Synthesis Inhibitors
1
2014
1
0.030
Why?
Puromycin
1
2014
1
0.030
Why?
Cytochrome P-450 CYP2E1
1
2014
4
0.030
Why?
Cell Line, Transformed
1
2014
5
0.030
Why?
Sri Lanka
1
2014
1
0.030
Why?
Decalcification Technique
2
1992
2
0.030
Why?
Radiography
2
1992
49
0.030
Why?
Cytochrome P-450 Enzyme System
1
2014
106
0.030
Why?
Analysis of Variance
1
2013
25
0.030
Why?
Remission Induction
1
2013
25
0.030
Why?
Absorptiometry, Photon
1
2012
16
0.030
Why?
Evidence-Based Medicine
1
2012
41
0.030
Why?
Clinical Trials as Topic
1
2012
43
0.030
Why?
Curettage
1
1992
1
0.030
Why?
Fibrous Dysplasia of Bone
1
1992
1
0.030
Why?
Fibroma
1
1992
2
0.030
Why?
Osteoma
1
1992
3
0.030
Why?
Hospitals, Pediatric
1
2012
178
0.020
Why?
Vitamin D3 24-Hydroxylase
1
2010
2
0.020
Why?
COS Cells
1
2010
17
0.020
Why?
Steroid Hydroxylases
1
2010
12
0.020
Why?
Amino Acid Sequence
1
2010
31
0.020
Why?
Binding Sites
1
2010
27
0.020
Why?
Molecular Sequence Data
1
2010
72
0.020
Why?
Fibroblasts
1
2010
26
0.020
Why?
Cells, Cultured
1
2010
81
0.020
Why?
Injections, Intravenous
1
2008
13
0.020
Why?
Catheters, Indwelling
1
2007
30
0.020
Why?
Time
1
2006
7
0.020
Why?
Osteogenesis
1
2006
6
0.020
Why?
Transplantation, Homologous
1
1988
21
0.000
Why?
Neoplasm Recurrence, Local
1
1988
34
0.000
Why?
Srivastava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_